Tralokinumab is effective for the treatment of AD through 72 weeks across body regions, including the head/neck, trunk, and limbs.
(A) Details on the protocol for mounting a silica bead onto a flat-tipped cantilever. (B) The procedure for securing leptomeninges on the AFM measurement plate for analysis. The meninges act as a key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results